PYXS
Pyxis Oncology (PYXS)
$
24About Pyxis Oncology (PYXS)
Pyxis Oncology, Inc. engages in the business of developing a multi-modality portfolio of next-generation therapeutics to target difficult-to-treat cancers and improve quality of life for patients. The firm focuses on the development of product candidates to directly kill tumor cells and to address the underlying pathologies created by cancer that enable its uncontrollable proliferation and immune evasion. The company was founded by David Steinberg, Shaan C. Gandhi, and John L. Flavin on June 11, 2018 and is headquartered in Boston, MA.
Details
Daily high
$3.42
Daily low
$3.11
Price at open
$3.18
52 Week High
$6.85
52 Week Low
$1.35
Market cap
192.5M
Dividend yield
0.00%
Volume
506,380
Avg. volume
525,710
P/E ratio
-2.58
Pyxis Oncology News
Details
Daily high
$3.42
Daily low
$3.11
Price at open
$3.18
52 Week High
$6.85
52 Week Low
$1.35
Market cap
192.5M
Dividend yield
0.00%
Volume
506,380
Avg. volume
525,710
P/E ratio
-2.58